Compare Inovio Pharmaceuticals Inc (INO) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Tractor Supply Co — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Tractor Supply Co trades at $36.19 (market cap $18.39B). The key difference: Tractor Supply Co is far larger — about 234.1× Inovio Pharmaceuticals Inc's market cap, and Tractor Supply Co pays a 2.72% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | TSCO | |
|---|---|---|
Market Cap | $78.55M | $18.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $62.65 |
52-Week Low | $0.66 | $29.14 |
Enterprise Value | $49.56M | $24.70B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $0.76, up 2.74% today, but remains in a bearish technical trend. The company shows minimal revenue of $65K against high operating losses, with a net income margin of -130,000%. Recent quarterly EPS has beaten expectations. Analyst consensus is bullish with a $3.25 price target, but the stock faces significant fundamental challenges including negative cash flow and high valuation multiples.
The outlook hinges on FDA approval of INO-3107 in October 2026, a binary event that could drive substantial upside. However, persistent cash burn, negative profitability, and ongoing shareholder litigation present high risks. Investors should weigh the potential catalyst against the company's weak financial health and operational execution challenges.
Tractor Supply (TSCO) trades at $36.24, up 4.68% today, with a mixed technical picture showing bullish moving averages but overbought RSI levels. Fundamentally, the company reported $15.52B in 2025 revenue with a net margin of 6.42%, though recent quarters saw EPS misses. Valuation metrics include a P/E of 18.38 and ROE of 39.51%, indicating strong profitability but high price-to-book at 6.99. Recent news highlights CEO share purchases and dividend declarations amid a 2026 outlook cut due to weak demand.
The stock presents a cautious opportunity with solid fundamentals offset by near-term headwinds. Upside potential exists from digital growth and pet initiatives, but risks include discretionary spending pressure and cost inflation. Analysts are divided, with a $36.29 price target suggesting limited upside from current levels, requiring careful monitoring of holiday sales and margin trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
